The Tesla Shock Nobody Sees Coming
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
About Sanofi ADR
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, yellow fever, and rabies vaccines. In addition, the company has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Innate Pharma SA for a natural killer cell engager program targeting B7-H3; and Blackstone Life Sciences to develop pivotal studies and clinical development program. Further, it has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop novel targeted protein degradation therapies; Denali Therapeutics Inc. to treat a range of systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for the discovery and development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab, as well as an strategic alliance with the Department of Health " Abu Dhabi for the development of global vaccines. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incor
General
Name | Sanofi ADR |
Ticker | SNY |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Currency | USD |
Country | USA |
Fiscal Year End | December |
Full Time Employees | 82,878 |
Highlights
Analyst Target | 64.04 |
Market Cap | 117,698,600,000 |
PE Ratio | 20.18 |
PEG Ratio | 0.78 |
EBITDA | 12,147,999,744 |
Share Stats
Shares Outstanding | 2,611,390,000 |
Shares Float | 2,435,900,000 |
Shares Short | 4,390,000 |
Insider Holdings | 0% |
Institution Holdings | 10.49% |
Highlights
Analyst Target | 64.04 |
Market Cap | 117,698,600,000 |
PE Ratio | 20.18 |
PEG Ratio | 0.78 |
EBITDA | 12,147,999,744 |
Valuation
Trailing PE | 16.62 |
Forward PE | 10.14 |
Price/Sales (Trailing 12 Mt.) | 2.62 |
Price/Book (Most Recent Quarter) | 1.37 |
Dividend
Sanofi ADR pays out a dividend of $2.38 per share, with a dividend yield of 4.93%.
SNY's last dividend payment was made to shareholders on June 12, 2025.
They pay out 66.53% of their earnings out as a dividend.
Recent Dividends
Jun 12, 2025 | $2.21 |
Jun 6, 2024 | $2.04 |
1.4M of the nation's poorest renters risk losing their homes with Trump's proposed HUD time limit
WOODINVILLE, Wash. (AP) — Havalah Hopkins rarely says no to the chain restaurant catering gigs that send her out to Seattle-area events — from church potlucks to office lunches and graduation parties.
Barbara Corcoran, Who Sold Her Real Estate Empire For $66 Million Decades Ago, Says This Is The 'Most Under-Utilized' Tool In The Workplace
Real estate millionaire Barbara Corcoran built a $20 billion brokerage by making work fun with picnics, rewards, and perks, not strict rules.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
ASML Stock Plunges Nearly 8% In Wednesday Pre-Market: What's Going On?
Shares of Dutch semiconductor firm, ASML Holding NV (NASDAQ: ASML), has declined 7.46% during Wednesday pre-market trading, after the company expressed concerns over its 2026 growth prospects.
Faced with geopolitics and trade war, US companies in China report record-low new investment plans
WASHINGTON (AP) — American companies in China are reporting record-low new investment plans for this year and declining confidence in profits, while uncertainty in U.S.-China relations and President Donald Trump’s tariffs have become their top concerns, according to a business survey released Wednesday.
Trump's Fast-Track Plan: These 3 Stocks Are Set to Soar - Ad
AI isn't the only game-changer on Wall Street right now. President Trump is fast-tracking a select group of U.S. companies-quietly accelerating their growth and profit potential. According to legendary investor Louis Navellier, this move could ignite a massive stock surge...And he's identified three companies that stand to benefit most.
Trump's bid to claw back $9B in foreign aid and public broadcasting funds nears Senate vote
WASHINGTON (AP) — President Donald Trump's request to cancel about $9 billion in foreign aid and public broadcasting spending is nearing passage in the Senate, an action that would have a tiny impact on the nation's rising debt but could have major ramifications for future spending fights in Congress.
Do as I say, not as I do: On my failings as an investor
If a knowledgeable observer trained his or her sights on my choices, what are the trouble spots they would identify? Here are some of the biggies.
Gold Just Hit Another Record. This Junior Could Be Next. - Ad
This copper junior was the smallest company invited to a top global mining conference. With nearly 1B pounds CuEq and 50,000m of funded drilling, this story won't stay quiet for long.
Robinhood Just Made Crypto Simpler — And Way More Powerful
Robinhood Markets (NASDAQ:HOOD) has made a significant push into crypto, unveiling a suite of inno
Feihe Struggles Amid China's Dairy Oversupply And Falling Birth Rates
Declining birth rates and China's slowing economy are taking a toll on the company and its peers as they grapple with oversupply and asset impairments on excess inventory
Robotics Meets Public Safety Innovation - Ad
Advanced security robots, real-world impact, and a valuation gap too big to ignore. This robotics stock is one to watch.
T. Rowe Price: Why Shares Could See Prolonged Underperformance
T. Rowe Price stock has entered the final phase of its Adhishthana Cycle, signaling potential long-term underperformance as structural weakness sets in.
Asian shares mostly decline as worries continue over Trump's tariffs
TOKYO (AP) — Asian shares were mostly lower in early Tuesday trading, as worries about President Donald Trump’s latest weighed on investor sentiments.
Copper's Spiking - And This Junior Has the Grades to Match - Ad
Copper is climbing again - and this time, it looks tariff-proof. A $31M junior just posted nearly 1B lbs of copper equivalent. With insiders and institutions piling in, this could be the next breakout.
Circle CEO: Stablecoins Are Going Mainstream — Fast
Jeremy Allaire, CEO of Circle Internet Group, Inc. (NYSE:CRCL), is offering a compelling vision for the future of digital finance and the role of stablecoins in the global economy.
Intel (INTC) Stock Falls On Report Of Major Chip Strategy Shift
Intel shares are trading lower Wednesday afternoon. CEO Lip-Bu Tan is reportedly considering a strategic pivot away from marketing its costly 18A chipmaking process.
The Robotics Underdog Ready to Run - Ad
An AI robotics company cutting crime by 46% and scaling fast-yet its valuation lags behind peers.
AstraZeneca In $15 Billion Talks For Drug That Could Upend Lung Cancer Treatment
AstraZeneca is in advanced talks with Summit Therapeutics over a potential $15 billion deal for the lung cancer drug ivonescimab.
Cramer Praises Monster Beverage As 'Smoking Hot,' Warns Investors About This AI Stock
Cramer recommends buying Okta (OKTA) as it reported strong earnings, but not to trust Nebius Group (NBIS), while Sweetgreen (SG) and Monster Beverage (MNST) have mixed views. He also suggests buying McDonald's (MCD) while their partnership with Krispy Kreme (DNUT) will end in 2025.
The Pentagon Is Stockpiling and This Company Is Poised With a "Tier 1 Priority" Resource - Ad
America is racing to rebuild its domestic supply of strategic materials. One company with projects across key allied nations is in the right place at the right time.
Paramount to pay $16 million in settlement with Trump over '60 Minutes' interview
In a case seen as a challenge to free speech, Paramount has agreed to pay $16 million to settle a lawsuit filed by President Donald Trump over the editing of CBS' “60 Minutes” interview with then-Vice President Kamala Harris in October.
Elon Musk's SpaceX's Hypersonic Rocket Cargo Delivery Project Dropped By US Air Force
The U.S. Air Force has decided to terminate a project in collaboration with Elon Musk's SpaceX.
Elon's Greatest Invention... Hidden in South Memphis? - Ad
In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.
FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff
WASHINGTON (AP) — The working under Health Secretary recently of two COVID-19 vaccines, disregarding recommendations from government scientists, according to federal documents released Wednesday.
Trump's Approval Ratings, Tariff Deadlines, Schumer's Criticism, And Defense Budget Shifts: This Week In Politics
Trump's approval ratings drop after Iran attack, hints at tariff deadline flexibility. SC limits judges' power, Schumer criticizes GOP budget, defense budget shifts to missiles and drones.
Robotics Valuation Gap: Who Will Win? - Ad
Two companies. Same sector. Vastly different valuations. One brings in millions in revenue, the other, barely a fraction. The market hasn't caught on yet.
Whitmer says 'massive economic uncertainty' is to blame on semiconductor project failure in Michigan
LANSING, Mich. (AP) — Plans to build a semiconductor manufacturing plant in Michigan have fallen through and Democratic Gov. Gretchen Whitmer said Wednesday that “massive economic uncertainty” is to blame.
Boeing Rises 2.8% After Key Trading Signal
A significant trading signal occurred for Boeing stock, as it demonstrated a power inflow at $209.02, after which BA rose up to 2.8%.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Palantir, Anduril, Erebor: Peter Thiel, The Lord Of The Finance Rings
Palantir, Anduril and Erebor borrow their names from Tolkien's "The Lord of the Rings."
Rivian Unseats Lucid, DraftKings Ousts Plug Power In Russell 1000 Shake-Up
Here's a look at notable additions and exclusions from the Russell 1000 index.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Cathie Wood Doubles Down On Tesla Amid Elon Musk's Feud With Trump, Sells $3 Million Worth Of Coinbase Stock
On Tuesday, Cathie Wood-led Ark Invest made significant trades involving Tesla Inc. and Coinbase Global Inc. . These trades reflect Ark’s strategic positioning amid ongoing market developments.
Trump branded, browbeat and prevailed. But his big bill may come at a political cost
WASHINGTON (AP) — Barack Obama had the . Joe Biden had the . will have the .
Trump's Fast-Track Plan: These 3 Stocks Are Set to Soar - Ad
AI isn't the only game-changer on Wall Street right now. President Trump is fast-tracking a select group of U.S. companies-quietly accelerating their growth and profit potential. According to legendary investor Louis Navellier, this move could ignite a massive stock surge...And he's identified three companies that stand to benefit most.
Donald Trump Drops Hint About Potential TikTok Buyer, But Keeps Details Close To His Chest
President Trump has indicated the presence of a potential buyer for the US operations of TikTok.
Home Depot's $5.5B Deal Expands Its Reach To Thousands Of Job Sites
Analyst maintains Buy rating on Home Depot with $450 price target, noting plans for subsidiary SRS Distribution to acquire GMS for $4.3B.
Gold Just Hit Another Record. This Junior Could Be Next. - Ad
This copper junior was the smallest company invited to a top global mining conference. With nearly 1B pounds CuEq and 50,000m of funded drilling, this story won't stay quiet for long.
Elon Musk Renews Demand for Jeffrey Epstein Files Release, Weeks After Alleging Trump Is Named in Them
Elon Musk has once again demanded the release of the unredacted Jeffrey Epstein files. This comes in the wake of his allegations against President Trump.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.